Richard D. Carvajal, MD

home / authors / richard-d-carvajal-md

Articles

Prognostic Value of Low Tumor Burden in Patients With Melanoma

Andrew S. Poklepovic, MD;Richard D. Carvajal, MD

September 18th 2018

In this article, we review the role of baseline tumor size in response and survival on traditional and contemporary therapies for the treatment of locoregional and distant melanoma recurrences.

Secondary Prevention Strategies for Nonmelanoma Skin Cancer

Adriana T. Lopez, BA;Richard D. Carvajal, MD;Larisa Geskin, MD

April 15th 2018

In this article, we review the published literature and evaluate secondary prevention strategies for nonmelanoma skin cancer. We also explore investigational therapies proposed for chemoprevention of nonmelanoma skin cancers.

Mucosal Melanoma: New Insights and Therapeutic Options for a Unique and Aggressive Disease

Benjamin A. Lerner, MD;Latoya A. Stewart;David P. Horowitz, MD;Richard D. Carvajal, MD

November 15th 2017

Here, we review the features of mucosal melanoma that distinguish it from melanomas arising at other sites, and we highlight recent biological discoveries and emerging treatment options for this aggressive disease.

Clinical Management of Uveal and Conjunctival Melanoma

Elyse S. Blum, PhD;Jessica Yang, MD;Kimberly M. Komatsubara, MD;Richard D. Carvajal, MD

January 15th 2016

In this review, we discuss current management strategies, as well as future directions, for the management of uveal and conjunctival melanoma.

Melanoma and Other Skin Cancers

Richard D. Carvajal, MD;Ashfaq A. Marghoob, MD;Aradhana Kaushal, MD;Jason D. Kehrer, DO;Mary S. Brady, MD

November 1st 2015

Skin cancer is the single most common form of cancer, accounting for more than 75% of all cancer diagnoses. More than 1 million cases of squamous cell and basal cell carcinomas are diagnosed annually, with a lifetime risk of more than one in five.